Beta-arrestin signaling and microRNA biogenesis in cardioprotection

心脏保护中的 Beta-arrestin 信号传导和 microRNA 生物发生

基本信息

  • 批准号:
    9313749
  • 负责人:
  • 金额:
    $ 38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-08-11 至 2019-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Heart failure (HF) is a major public health problem affecting more than 5 million Americans. The total healthcare costs of HF are over $30 billion annually, and are projected to increase as the population ages. Therefore, there is a critical need to develop innovative strategies for prevention and treatment of HF. �1-adrenergic receptor (�1AR, a seven transmembrane G protein-coupled receptor) signaling is critical to sympathetic regulation of cardiac function, but becomes deleterious in response to chronic catecholamine stimulation during the progression of HF. More recently, it became appreciated that �1AR signaling involves multiple pathways including a novel cardioprotective signaling (CPS) pathway, in which �1AR uses �-arrestin (�-arr) to promote cardiomyocyte (CM) survival in the absence of G protein activation. However, the molecular mechanisms in downstream nuclear processes by which �-arr-mediated �1AR signaling confers cardiac protection are not well understood. Based on increasing recognition of microRNAs (miRs) as important regulators of cardiovascular function, we postulated that miR may represent under-appreciated downstream mechanisms regulating the �-arr- mediated cardioprotection. Our preliminary data show that �1AR-mediated activation of �-arr1 enhanced miR processing and expression of several miRs that are known to regulate cell survival and apoptotic pathways. However, the importance of increased �-arr1-regulated miRs (�1-miRs) to the outcome of cardiac function and tissue injury is unknown and a goal of the current study. The objective of this application is to define the importance of a �1-miR, miR-150 and two of its CM target genes (pro-apoptotic egr2 and p2x7r) in �1AR-mediated �-arrestin1 CPS. The central hypothesis is that �-arr1- mediated �1AR regulatory mechanisms confer cardioprotection against myocardial infarction (MI) and chronic catecholamine stimulation via miR-150 processing and altered expression of the two target genes. Guided by extensive preliminary data, our hypothesis will be tested by pursuing three specific aims: 1) Determine if miR-150 modulates cardiac functional responses to coronary ligation and chronic catecholamine stimulation. In vivo loss- and gain-of-function approaches in response to MI and chronic catecholamine treatment will be employed in mice. 2) Determine if increased expression of miR-150 contributes to carvedilol (a �-arr-biased �-blocker)-mediated cardioprotection. Both genetic and pharmacological approaches will be used in CM and whole hearts. 3) Elucidate the roles of egr2 and p2x7r, functional CM targets of miR- 150, in HF. Loss- and gain-of-function studies of targets will be performed to show their importance in CM survival and cardiac protection. The proposed work is innovative because the regulation of miR expression by �-arr signaling has never been studied. We will discover novel regulatory mechanisms of miR processing and function by �-arrestin1-biased �1AR signaling pathways and identify potentially important miR-target pairs that are involved in CPS. The proposed re- search is significant because the ability of �-arr1-biased agonism of �1AR to regulate cardioprotective miR/pro-apoptotic target pairs holds promise for pharmacological manipulation of HF. Ultimately, such knowledge has the potential to inform the development of novel approaches for the prevention and treatment of a variety of cardiac diseases.
描述(由申请者提供):心力衰竭(HF)是一个主要的公共健康问题,影响着500多万美国人。心力衰竭的总医疗费用每年超过300亿美元,预计随着人口老龄化而增加。因此,迫切需要制定预防和治疗心力衰竭的创新战略。�1肾上腺素能受体(�1AR,一种7种跨膜G蛋白偶联受体)信号对心功能的交感神经调节至关重要,但在心力衰竭进展过程中,由于慢性儿茶酚胺刺激,信号变得有害。最近,人们意识到�1AR信号涉及多个途径,其中包括一条新的心肌保护信号通路,在该通路中,�1AR使用�-arrestin(�-ARR)在没有G蛋白激活的情况下促进心肌细胞(CM)的存活。然而,�-ARR介导的�1AR信号在下游核过程中发挥心脏保护作用的分子机制尚不清楚。基于越来越多的人认识到�(MiRs)是心血管功能的重要调节因子,我们推测microRNAs(MiRs)可能代表了调节microRNAs-arr介导的心脏保护的下游机制。我们的初步数据表明,�1AR介导的�-Arr1的激活促进了miR的处理和几个已知调节细胞生存和凋亡途径的miR的表达。然而,增加的�-Arr1调节的MIR(�1-MIR)对心功能和组织损伤结局的重要性尚不清楚,也是当前研究的目标之一。本应用的目的是确定�1-miR、miR-150及其两个CM靶基因(促凋亡基因egr2和P2X7R)在�1AR介导的�-arrestin1CP中的重要性。中心假说是,�-Arr1介导的�1AR调节机制通过miR-150处理和改变两个靶基因的表达,对心肌梗死(MI)和慢性儿茶酚胺刺激提供心脏保护。在大量初步数据的指导下,我们的假设将通过追求三个具体目标来检验:1)确定miR-150是否调节对冠状动脉结扎和慢性儿茶酚胺刺激的心功能反应。在活体内,对心肌梗塞和慢性儿茶酚胺治疗的反应将采用功能丧失和功能获得的方法。2)确定miR150的表达增加是否有助于卡维地洛(一种�-ARR偏向的�阻滞剂)介导的心脏保护作用。遗传和药理学方法都将用于CM和整个心脏。3)阐明miR-150的功能性CM靶点egr2和P2X7R在心力衰竭中的作用。将进行靶点功能丧失和功能恢复的研究,以显示它们在CM存活和心脏保护中的重要性。提出的工作是创新的,因为�-ARR信号对miR表达的调控从未被研究过。我们将通过�-arrestin1偏向的�1AR信号通路发现miR处理和功能的新调控机制,并识别参与CP的潜在重要miR靶点对。这项研究意义重大,因为�-Arr1偏向的�1AR激动剂调节心肌保护性miR/促凋亡靶点对的能力为HF的药理操作提供了希望。最终,这些知识有可能为各种心脏病预防和治疗的新方法的开发提供信息。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Il-man Kim其他文献

Il-man Kim的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Il-man Kim', 18)}}的其他基金

Identifying novel pathways targeting endothelial-to-mesenchymal transition during heart failure
确定心力衰竭期间针对内皮间质转化的新途径
  • 批准号:
    9978603
  • 财政年份:
    2019
  • 资助金额:
    $ 38万
  • 项目类别:
Identifying novel pathways targeting endothelial-to-mesenchymal transition during heart failure
确定心力衰竭期间针对内皮间质转化的新途径
  • 批准号:
    10207753
  • 财政年份:
    2019
  • 资助金额:
    $ 38万
  • 项目类别:
Identifying novel pathways targeting endothelial-to-mesenchymal transition during heart failure
确定心力衰竭期间针对内皮间质转化的新途径
  • 批准号:
    10438710
  • 财政年份:
    2019
  • 资助金额:
    $ 38万
  • 项目类别:
Beta-arrestin signaling and microRNA biogenesis in cardioprotection
心脏保护中的 Beta-arrestin 信号传导和 microRNA 生物发生
  • 批准号:
    8766257
  • 财政年份:
    2014
  • 资助金额:
    $ 38万
  • 项目类别:

相似海外基金

Structural basis for regulation of beta2 adrenergic receptor signaling by the dynamic post-translational modification S-palmitoylation
动态翻译后修饰S-棕榈酰化调节β2肾上腺素受体信号传导的结构基础
  • 批准号:
    10603466
  • 财政年份:
    2023
  • 资助金额:
    $ 38万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2022
  • 资助金额:
    $ 38万
  • 项目类别:
    Discovery Grants Program - Individual
Glucocorticoid and Adrenergic Receptor Signaling at the Neuroimmune Interface
神经免疫界面的糖皮质激素和肾上腺素能受体信号传导
  • 批准号:
    RGPIN-2019-04706
  • 财政年份:
    2022
  • 资助金额:
    $ 38万
  • 项目类别:
    Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574979-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 38万
  • 项目类别:
    University Undergraduate Student Research Awards
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
  • 批准号:
    10629280
  • 财政年份:
    2022
  • 资助金额:
    $ 38万
  • 项目类别:
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
  • 批准号:
    10448574
  • 财政年份:
    2022
  • 资助金额:
    $ 38万
  • 项目类别:
Novel regulation of beta-adrenergic receptor function by phosphoinositide 3-kinase
磷酸肌醇 3-激酶对 β-肾上腺素能受体功能的新调节
  • 批准号:
    10591688
  • 财政年份:
    2022
  • 资助金额:
    $ 38万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574984-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 38万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574985-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 38万
  • 项目类别:
    University Undergraduate Student Research Awards
The molecular mechanism of the crosstalk between the beta-2 adrenergic receptor and chemokine receptors in lymphocytes
淋巴细胞β2肾上腺素受体与趋化因子受体串扰的分子机制
  • 批准号:
    22K07118
  • 财政年份:
    2022
  • 资助金额:
    $ 38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了